Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Biomed Lublin Wytwornia Surowic i Szczepionek SA banner
B

Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML

Watchlist Manager
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
Watchlist
Price: 5.8 PLN 1.67% Market Closed
Market Cap: zł378.5m
Write Note Create Alert Ask AI

Gross Margin

56.9%
Current
No historical data
Comparison unavailable

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
56.9%
=
Gross Profit
zł30.6m
/
Revenue
zł53.8m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
56.9%
=
Gross Profit
zł30.6m
/
Revenue
zł53.8m

Peer Comparison

Country Company Market Cap Gross
Margin
PL
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
407.5m PLN
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
409.8B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
198.7B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
193.1B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.5B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
84.3B USD
Loading...
AU
CSL Ltd
ASX:CSL
72.6B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.1B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Higher than 70% of companies in Poland
Percentile
70th
Based on 787 companies
70th percentile
56.9%
Low
-535 500% — 18.1%
Typical Range
18.1% — 55.9%
High
55.9% — 807.1%
Distribution Statistics
Poland
Min -535 500%
30th Percentile 18.1%
Median 30.2%
70th Percentile 55.9%
Max 807.1%

Other Profitability Ratios

Biomed Lublin Wytwornia Surowic i Szczepionek SA
Glance View

Market Cap
378.5m PLN
Industry
Biotechnology

Biomed Lublin Wytwornia Surowic i Szczepionek SA engages in the manufacture of pharmaceutical products. The company is headquartered in Lublin, Woj. Lubelskie and currently employs 223 full-time employees. The company went IPO on 2011-07-29.

BML Intrinsic Value
Not Available
B
What is Intrinsic Value?

See Also

Summary
BML intrinsic value, competitors valuation, and company profile.
DCF Valuation
BML stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BML stock valuation using valuation multiples.
Wall Street Estimates
BML price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BML stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
56.9%
=
Gross Profit
zł30.6m
/
Revenue
zł53.8m
What is Biomed Lublin Wytwornia Surowic i Szczepionek SA's current Gross Margin?

The current Gross Margin for Biomed Lublin Wytwornia Surowic i Szczepionek SA is 56.9%, which is in line with its 3-year median of 56.9%.

How has Gross Margin changed over time?

Over the last 3 years, Biomed Lublin Wytwornia Surowic i Szczepionek SA’s Gross Margin has increased from 54.8% to 56.9%. During this period, it reached a low of 49% on Sep 30, 2020 and a high of 56.9% on May 1, 2023.

Back to Top
ALPHA SPREAD
Follow us
Join more than 317,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.